FDA User Fee Hearing Hijacked By US Health Care Reform Arguments

Democrats used a Senate hearing on the US FDA's user fee program to attempt to reframe the drug pricing debate, arguing that the GOP's plan to speed generic approvals may not be enough to drive down prices.

While Republicans have held up the generic drug user fee program as an answer to increasing drug prices, namely because it can create more competition for high-priced brand and single-source generics, Sen